Literature DB >> 19806512

The efficacy and safety of human oocyte cryopreservation by slow cooling.

Andrea Borini1, Giovanni Coticchio.   

Abstract

Preservation at low temperatures is a practice that has found several applications in medicine and biotechnology. Several types of cells and tissues can be stored virtually indefinitely in liquid nitrogen (-196 degrees C) and returned to physiological temperatures. However, phenomena occurring during cooling and warming may affect the structure and function of the stored material. To some extent, the use of substances with special protective properties, referred to as cryoprotective agents, may avoid this effect, but normally a fraction of the cryopreserved material suffers a partial or total loss of viability. In the context of human in vitro fertilization (IVF), for decades cryopreservation has been used to store different materials of reproductive function, mainly embryos at various developmental stages and spermatozoa. In recent times, the realm of cryopreservation has been expanded to also include fully grown unfertilized oocytes. The storage of oocytes offers obvious advantages, eluding legal and ethical problems that afflict, and sometimes make inapplicable, embryo cryopreservation. Until recently, technical and applicative advances of oocyte cryopreservation were inhibited by the preconception that the unique nature of this cell was an insurmountable obstacle to safe and efficient preservation at low-temperature storage. In fact, through the two alternative methodological approaches of controlled rate slow cooling and vitrification, oocyte cryopreservation has been developed both technically and clinically to a stage that is beginning to challenge the supremacy of embryo freezing as the preferred form of fertility preservation for the treatment of infertile couples. Although several questions remain to be answered as to whether oocyte cryopreservation can ensure adequate standards of efficacy and safety, there appears to be little doubt that in the near future oocyte cryopreservation will be recognized as an established form of IVF treatment. Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19806512     DOI: 10.1055/s-0029-1241053

Source DB:  PubMed          Journal:  Semin Reprod Med        ISSN: 1526-4564            Impact factor:   1.303


  9 in total

Review 1.  Oocyte cryopreservation: searching for novel improvement strategies.

Authors:  Natalie A Clark; Jason E Swain
Journal:  J Assist Reprod Genet       Date:  2013-06-19       Impact factor: 3.412

2.  Cumulus-oocyte complexes from small antral follicles during the early follicular phase of menstrual cycles in rhesus monkeys yield oocytes that reinitiate meiosis and fertilize in vitro.

Authors:  Marina C Peluffo; Susan L Barrett; Richard L Stouffer; Jon D Hennebold; Mary B Zelinski
Journal:  Biol Reprod       Date:  2010-06-02       Impact factor: 4.285

3.  Effects of vitrification and cryostorage duration on single-cell RNA-Seq profiling of vitrified-thawed human metaphase II oocytes.

Authors:  Ying Huo; Peng Yuan; Qingyuan Qin; Zhiqiang Yan; Liying Yan; Ping Liu; Rong Li; Jie Yan; Jie Qiao
Journal:  Front Med       Date:  2020-09-02       Impact factor: 4.592

4.  Cryopreservation of Mammalian Oocytes: Slow Cooling and Vitrification as Successful Methods for Cryogenic Storage.

Authors:  Victoria Keros; Barry J Fuller
Journal:  Methods Mol Biol       Date:  2021

5.  Design and characterization of genetically engineered zebrafish aquaporin-3 mutants highly permeable to the cryoprotectant ethylene glycol.

Authors:  François Chauvigné; Esther Lubzens; Joan Cerdà
Journal:  BMC Biotechnol       Date:  2011-04-08       Impact factor: 2.563

6.  Slow oocyte freezing and thawing in couples with no sperm or an insufficient number of sperm on the day of in vitro fertilization.

Authors:  Irma Virant-Klun; Liljana Bacer-Kermavner; Tomaz Tomazevic; Eda Vrtacnik-Bokal
Journal:  Reprod Biol Endocrinol       Date:  2011-02-02       Impact factor: 5.211

7.  Oocyte vitrification modifies nucleolar remodeling and zygote kinetics-a sibling study.

Authors:  S Chamayou; S Romano; C Alecci; G Storaci; C Ragolia; A Palagiano; A Guglielmino
Journal:  J Assist Reprod Genet       Date:  2015-02-21       Impact factor: 3.412

8.  An improved model for nucleation-limited ice formation in living cells during freezing.

Authors:  Jingru Yi; Xin M Liang; Gang Zhao; Xiaoming He
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

9.  Addition of Cryoprotectant Significantly Alters the Epididymal Sperm Proteome.

Authors:  Sung-Jae Yoon; Md Saidur Rahman; Woo-Sung Kwon; Yoo-Jin Park; Myung-Geol Pang
Journal:  PLoS One       Date:  2016-03-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.